Epiluvac AB Revenue and Competitors
Estimated Revenue & Valuation
- Epiluvac AB's estimated annual revenue is currently $340k per year.
- Epiluvac AB's estimated revenue per employee is $85,000
Employee Data
- Epiluvac AB has 4 Employees.
- Epiluvac AB grew their employee count by 0% last year.
Epiluvac AB's People
Name | Title | Email/Phone |
---|
Epiluvac AB Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $19.4M | 114 | -37% | N/A | N/A |
#2 | $1.1M | 11 | 0% | N/A | N/A |
#3 | $5.6M | 41 | N/A | N/A | N/A |
#4 | $5780M | 7726 | 8% | N/A | N/A |
#5 | $9.9M | 65 | 5% | N/A | N/A |
#6 | $41.7M | 223 | 24% | N/A | N/A |
#7 | $24270M | 27863 | 21% | $4B | N/A |
#8 | $207.3M | 871 | N/A | N/A | N/A |
#9 | $4M | 52 | 8% | N/A | N/A |
#10 | $4.2M | 31 | N/A | N/A | N/A |
What Is Epiluvac AB?
We provide flexible reactor systems for Wide Band Gap (WBG) semiconductors (SiC/GaN/AlN etc). Epiluvac is a privately held Swedish company founded 2013 by a team of engineers with decades of research and development experience from the CVD reactor field and especially hot-wall CVD SiC epitaxy equipment. The company offers CVD and MOCVD reactors and process chambers for high purity and high temperatures with customized gas mixing systems. Applications include epitaxy and bulk growth of WBG compound semiconductors like silicon carbide (SiC) and gallium nitride (GaN) but also graphene and nanowire manufacturing. Epiluvac provides standard as well as customized reactor solutions and a wide range of service and maintenance packages.
keywords:N/AN/A
Total Funding
4
Number of Employees
$340k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Epiluvac AB News
Smoltek Nanotech Holding AB (Smoltek) meddelar att bolagets valberedning föreslår att ... CG Drives & Automation AB, Norstel och Epiluvac.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.5M | 7 | -42% | N/A |
#2 | $0.8M | 8 | -11% | N/A |
#3 | $0.6M | 9 | 13% | N/A |
#4 | $0.6M | 9 | -53% | N/A |
#5 | $1.5M | 9 | -10% | N/A |